The global antacid market was valued at USD 7.02 Billion in 2024, driven by the rising prevalence of gastroesophageal reflux disease and other acid-related disorders across the globe. The market is anticipated to grow at a CAGR of 3.20% during the forecast period of 2025-2034, with the values likely to reach USD 9.62 Billion by 2034.
Base Year
Historical Year
Forecast Year
In October 2024, Akums Drugs launched a dual-action chewable tablet in India, offering rapid relief for gastroesophageal reflux disease and enhancing treatment effectiveness. The development of such advanced antacids tailored to specific conditions is a major market trend.
In March 2024, ENO launched chewy bites which highlight the brand's innovation in the antacid market, offering a convenient, on-the-go solution for acidity. Such innovations are expected to augment the market demand significantly in the forecast period.
The ongoing research and development efforts to improve the production of antacids are likely to elevate the market value in the coming years.
Antacids are commonly utilized medications that counteract excessive stomach acid, offering relief from heartburn, indigestion, and acid reflux. These are accessible without a prescription in different forms like tablets and liquids, providing rapid and effective relief from symptoms. The market is driven by advancements in formulations, changing consumer health trends, and heightened awareness of digestive wellness. The increasing occurrence of acid-related issues, combined with progress in medical research and regulatory backing, fuels the ongoing expansion of the antacids market, improving the quality of life for numerous individuals.
Rising Prevalence of Gastroesophageal Reflux Disease To Boost Market Growth
The growing prevalence of gastroesophageal reflux disease, affecting around 30% of individuals in Western societies, significantly contributes to the expansion of the global antacid market. With gastroesophageal reflux disease being one of the most common disorders in primary care, the demand for effective antacid medications has surged. The increasing incidence of gastroesophageal reflux disease-related symptoms such as heartburn and regurgitation, alongside complications like esophageal injury, drives both preventive and symptomatic treatments, fueling market growth.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Dosage Form
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by Region
Segmentation Based on Distribution Channel to Witness Substantial Growth
The distribution channel segment is divided into hospital pharmacies, retail pharmacies, and others. Retail pharmacies are anticipated to dominate the market share throughout the forecast period. Their ease of use, convenient locations, long operating hours, and rapid services contribute to their increasing popularity. Retail pharmacies provide a variety of medications, effective order processing systems, and tailored consultations with pharmacists, improving the overall customer experience. These elements play a crucial role in their market leadership, establishing retail pharmacies as a favored option for customers.
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market share because of a significant prevalence of gastrointestinal issues such as acid reflux and GERD, attributed to stress, unhealthy eating habits, and obesity. These lifestyle patterns drive the need for antacids as a quick way to relieve symptoms. On the other hand, the Asia Pacific region is projected to witness the fastest growth, as urbanization, shifting diets, heightened stress, and improved healthcare access augment the need for antacids, especially with the growing middle class and better affordability of over-the-counter products.
The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Bayer AG, a prominent global company in pharmaceuticals and biotechnology, boosted its presence in the antacid market through well-known brands such as Rennie and Alka-Seltzer. Alka-Seltzer is widely recognized for relieving digestive issues and associated pain.
Haleon plc, a prominent British multinational consumer healthcare firm located in Weybridge, England, is a major player in the global antacid market. Through reliable brands such as Eno and Tums, Haleon meets the increasing consumer demand for efficient digestive health solutions, promoting market growth via innovation and a robust global footprint.
Sun Pharma, a global leader in generic medications, propels market expansion through its vast product development and manufacturing expertise in complex formulations, active pharmaceutical ingredients, and over-the-counter offerings. Its cutting-edge digestive care products, such as pepmelt mouth-melt granules, pepfiz effervescent tablets, and pepfiz antacid powder, have broadened its reach in the global antacid market, addressing various consumer needs.
Procter & Gamble, a global healthcare leader, drives market growth through innovative products and strategic collaborations. A key player in the antacid market with its Rolaids brand, P&G expanded its reach in March 2024 by partnering with Lil' Drug Store Products to target heartburn sufferers. P&G's tactical investments in advertising, product improvements, and distribution strengthen Rolaids' competitive stance.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sanofi, WellSpring Pharmaceutical Corporation, Advance Pharmaceutical Inc., Reckitt Benckiser Group PLC, Teva Pharmaceuticals Industries Ltd., and Lupin.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Dosage Form |
|
| Breakup by Application |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share